| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 车前草苷D; Plantainoside D | CFN93188 | 147331-98-4 | C29H36O16 = 640.59 | 10mg | QQ客服：1457312923 |
| 紫茎女贞苷 A; Ligupurpuroside A | CFN93189 | 147396-01-8 | C35H46O19 = 770.73 | 5mg | QQ客服：2056216494 |
| 紫茎女贞苷 B; Ligupurpuroside B | CFN93190 | 147396-02-9 | C35H46O17 = 738.73 | 5mg | QQ客服：1413575084 |
| 斩龙剑苷A; Sibirioside A | CFN93209 | 173046-19-0 | C21H28O12 = 472.44 | 5mg | QQ客服：2056216494 |
| 球腺糖苷A; Glomeratose A | CFN93225 | 202471-84-9 | C24H34O15 = 562.52 | 5mg | QQ客服：1413575084 |
| 阿魏酸异丙酯; Isopropyl ferulate | CFN93263 | 59831-94-6 | C13H16O4 = 236.26 | 5mg | QQ客服：2159513211 |
| 阿魏酸松柏酯; Coniferyl ferulate | CFN93268 | 63644-62-2 | C20H20O6 = 356.37 | 10mg | QQ客服：3257982914 |
| 飞蓬酯乙; Erigoster B | CFN93294 | 849777-61-3 | C26H24O13 = 544.46 | 5mg | QQ客服：2159513211 |
| 肉苁蓉苷F; Cistanoside F | CFN93304 | 97411-47-7 | C21H28O13 = 488.44 | 5mg | QQ客服：1413575084 |
| 3-阿魏酸酯-1-芥子酰基蔗糖; 3-Feruloyl-1-Sinapoyl sucrose | CFN93305 | 98942-06-4 | C33H40O18 = 724.66 | 5mg | QQ客服：2159513211 |
| 6-O-(E)-咖啡酰基葡萄糖苷; 6-O-(E)-Caffeoylglucopyranose | CFN95105 | 209797-79-5 | C15H18O9 = 342.3 | 5mg | QQ客服：2159513211 |
| 3,5-O-二咖啡酰基奎宁酸; 3,5-di-O-caffeoylquinic acid | CFN93712 | 89919-62-0 | C25H24O12 = 516.45 | 5mg | QQ客服：3257982914 |
| 咖啡酸甲酯; Methyl caffeate acid | CFN95561 | 3843-74-1 | C10H10O4 = 194.18 | 5mg | QQ客服：215959384 |
| 党参苷I; Tangshenoside I | CFN95108 | 117278-74-7 | C29H42O18 = 678.6 | 10mg | QQ客服：2056216494 |
| 管花肉苁蓉苷C1; Cistantubuloside C1 | CFN95121 | 620632-36-2 | C35H46O21 = 802.7 | 10mg | QQ客服：1413575084 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)